Cambridge Investment Research Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,617
Closed -$223K 3240
2021
Q3
$223K Buy
4,617
+178
+4% +$8.24K ﹤0.01% 2719
2021
Q2
$201K Sell
4,439
-5,062
-53% -$224K ﹤0.01% 2836
2021
Q1
$458K Sell
9,501
-725
-7% -$37.7K ﹤0.01% 1960
2020
Q4
$551K Buy
10,226
+2,454
+32% +$111K ﹤0.01% 1707
2020
Q3
$287K Buy
7,772
+373
+5% +$13.9K ﹤0.01% 1973
2020
Q2
$229K Sell
7,399
-2,029
-22% -$56.2K ﹤0.01% 2085
2020
Q1
$260K Sell
9,428
-7,899
-46% -$237K ﹤0.01% 1762
2019
Q4
$507K Buy
17,327
+2,192
+14% +$52.2K ﹤0.01% 1569
2019
Q3
$289K Buy
15,135
+5,095
+51% +$120K ﹤0.01% 1849
2019
Q2
$220K Sell
10,040
-2,268
-18% -$49.8K ﹤0.01% 1947
2019
Q1
$252K Buy
+12,308
New +$214K ﹤0.01% 1916
2017
Q3
Sell
-13,100
Closed -$117K 2041
2017
Q2
$117K Sell
13,100
-500
-4% -$3.97K ﹤0.01% 1837
2017
Q1
$107K Buy
13,600
+1,000
+8% +$8.15K ﹤0.01% 1691
2016
Q4
$108K Buy
12,600
+1,000
+9% +$8.57K ﹤0.01% 1585
2016
Q3
$95K Sell
11,600
-3,700
-24% -$31K ﹤0.01% 1673
2016
Q2
$123K Buy
15,300
+3,450
+29% +$27.7K ﹤0.01% 1461
2016
Q1
$80K Hold
11,850
﹤0.01% 1529
2015
Q4
$93K Buy
+11,850
New +$86.8K ﹤0.01% 1495

Other funds holding NEO

Cambridge Investment Research Advisors's NEO Position: Q4 2021 in Review

Cambridge Investment Research Advisors sold out of NeoGenomics (NEO) in Q4 2021, closing a stake of 4,617 shares — an estimated $223K sold.

Cambridge Investment Research Advisors first reported a position in NEO in Q4 2015 and held it in 18 quarters. The position peaked at $551K in Q4 2020. 309 funds tracked by Wall St. Rank hold NEO as of Q4 2021.

  • Cambridge Investment Research Advisors reported no remaining NeoGenomics position as of Q4 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 4,617 NeoGenomics shares in Q4 2021, an estimated $223K.
  • Cambridge Investment Research Advisors first reported a position in NeoGenomics in Q4 2015 and held it in 18 quarters.
  • Cambridge Investment Research Advisors's NeoGenomics position peaked at $551K in Q4 2020.
  • 309 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.